Synapse - Hematology-Oncology Fellows

Results (1429)

Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)

Meeting Abstract

Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis

Meeting Abstract

Harrold, E.; Walch, H. S.; Chatila, W. K.; Kemel, Y.; Borio, M.; Maio, A.; Khurram, A.; Salo-Mullen, E. E.; Latham, A.; Murciano-Goroff, Y. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition

Meeting Abstract

Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical and molecular characterization of microsatellite stable (MSS) tumors in patients with Lynch syndrome (LS)

Meeting Abstract

Harrold, E.; Vanderbilt, C.; Maio, A.; Borio, M.; Ranganathan, M.; Sheehan, M.; O'Connor, C.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Redefining early-onset cancer and risk of hereditary cancer predisposition

Meeting Abstract

Stadler, Z. K.; Maio, A.; Khurram, A.; Kemel, Y.; Padunan, A.; Borio, M.; Sheehan, M.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)

Meeting Abstract

Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer

Meeting Abstract

Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Changes in PD-L1 and tumor mutational burden between paired samples and relationship to immune checkpoint inhibitor outcomes in non-small cell lung cancer

Meeting Abstract

Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V. M.; Wang, X.; Pecci, F.; Gandhi, M. M.; Lamberti, G.; Spurr, L. F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer

Meeting Abstract

Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)

Meeting Abstract

Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save